MSLead Chronicles

The line between Field Medical and Commercial is becoming harder to define. But are these functions truly becoming more alike, or have they always shared more than we acknowledged? In this episode, we examine the activities and capabilities that increasingly overlap, what still makes Field Medical distinct, and why these boundaries are shifting now. We also discuss what this evolution means for MSL careers as roles become more fluid and professionals gain more options for where their skills c...

Leadership doesn’t have to happen on a timeline. In this episode of MSLead Chronicles, Mary and Chad sit down with Shannon Payne, National Director of MSLs at BioCryst, to talk about a leadership path that didn’t begin with chasing the next title. Shannon moved into formal leadership after building a broad career in science, clinical development, and Medical Affairs. That experience shaped how she now thinks about influence, service, career development, and what it really means to lead people...

In this episode of MSLead Chronicles, we’re joined by **Mitch D’Rozario** to explore what actually makes a field observation a meaningful Medical Affairs insight and why collecting more information does not necessarily create more value. Mitch discusses how feedback loops, relationships, structured and unstructured data, and AI can help teams identify the signals that should influence strategy. He also shares common mistakes in insight gathering, including confirmation bias and over-escalatio...

If you've always wished you had a step by step guide to approach any situation, personal or professional, that will ensure the best possible result, this is the episode you won't want to miss. John Sandstrom walks us through M.O.R.E., a framework for guiding you to success in any circumstance. Mindfulness Outlook Relationships Empowerment

In this episode of MSLead Chronicles, Mary Morton and Chad Fellers sit down with rare disease Medical Affairs leader Teresa Fecteau to explore why lived experience must be more than a source of occasional feedback. It should be a consistent foundation for research, strategy, trial design, and decision-making. Teresa explains why patients, caregivers, and families often understand the realities of rare disease long before the science or healthcare system catches up. The conversation examines t...